Back
ProQR Therapeutics NV Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
PRQR
ProQR Therapeutics NV
Last Price:
$2.19
Seasonality Move:
13.33%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRQR is experiencing slight selling pressure.
ProQR Therapeutics NV Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.21 | Sell |
| 20-day SMA: | 2.2 | Sell |
| 50-day SMA: | 2.36 | Sell |
| 200-day SMA: | 2.02 | Buy |
| 8-day EMA: | 1.69 | Buy |
| 20-day EMA: | 0.98 | Buy |
| 50-day EMA: | 0.46 | Buy |
| 200-day EMA: | 0.13 | Buy |
ProQR Therapeutics NV Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 47.75 | Sell |
| Chaikin Money Flow: | -48269 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.06 - 2.3) | Sell |
| Bollinger Bands (100): | (2.03 - 2.53) | Sell |
ProQR Therapeutics NV Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProQR Therapeutics NV Stock
Is ProQR Therapeutics NV Stock a Buy?
-
ProQR Therapeutics NV share price is 2.17 while PRQR 8-day simple moving average is 2.21, which is a Sell signal.
-
The stock price of PRQR is 2.17 while ProQR Therapeutics NV 20-day SMA is 2.20, which makes it a Sell.
-
ProQR Therapeutics NV 50-day simple moving average is 2.36 while PRQR share price is 2.17, making it a Sell technically.
-
PRQR stock price is 2.17 and ProQR Therapeutics NV 200-day simple moving average is 2.02, creating a Buy signal.
PRQR Technical Analysis vs Fundamental Analysis
Buy
59
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy or a Sell?
-
ProQR Therapeutics NV stock is rated a BuyThe current ProQR Therapeutics NV [PRQR] share price is $2.17. The Score for PRQR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
ProQR Therapeutics NV Stock Info
Market Cap:
228.6M
Price in USD:
2.17
Share Volume:
144.8K
ProQR Therapeutics NV 52-Week Range
52-Week High:
3.10
52-Week Low:
1.07
Buy
59
ProQR Therapeutics NV (PRQR)
is a Buy
ProQR Therapeutics NV Share Price Forecast
-
What is the ProQR Therapeutics NV stock price today?The ProQR Therapeutics NV stock price is 2.17 USD today.
-
Will PRQR stock go up or go down?ProQR Therapeutics NV> share price is forecast to RISE/FALL based on technical indicators
-
Is ProQR Therapeutics NV overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProQR Therapeutics NV is not overvalued.
Is ProQR Therapeutics NV Stock a Buy?
-
ProQR Therapeutics NV share price is 2.17 while PRQR 8-day exponential moving average is 1.69, which is a Buy signal.
-
The stock price of PRQR is 2.17 while ProQR Therapeutics NV 20-day EMA is 0.98, which makes it a Buy.
-
ProQR Therapeutics NV 50-day exponential moving average is 0.46 while PRQR share price is 2.17, making it a Buy technically.
-
PRQR stock price is 2.17 and ProQR Therapeutics NV 200-day simple moving average is 0.13, creating a Buy signal.
Fundamental Analysis of ProQR Therapeutics NV
Is ProQR Therapeutics NV a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.08 per share.
Technical Analysis of ProQR Therapeutics NV
Should I short ProQR Therapeutics NV stock?
-
PRQR Moving Average Covergence Divergence (MACD) indicator is 0.57, suggesting ProQR Therapeutics NV is a Buy
-
ProQR Therapeutics NV Relative Strength Index (RSI) is 47.75, which suggest ProQR Therapeutics NV is oversold
-
The Bollinger Bands (25) for ProQR Therapeutics NV is (2.06 - 2.3), which suggest ProQR Therapeutics NV is a Sell
-
The Bollinger Bands (100) for ProQR Therapeutics NV is (2.03 - 2.53), which suggest ProQR Therapeutics NV is a Sell
* ProQR Therapeutics NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.